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Abstract
Background: Testing	for	human	papillomavirus	(HPV)	is	being	incorporated	into	the	cervi-
cal	screening	programme,	with	the	probable	future	introduction	of	HPV	as	a	primary	test	
and	a	possibility	of	HPV	self-	sampling.	In	anticipation	of	this	development,	we	sought	to	
inform	future	policy	and	practice	by	identifying	potential	barriers	to	HPV	self-	sampling.
Methods: A	cross-	sectional	survey	of	194	women	aged	20-	64	years	was	conducted.	
Logistic	regression	analysis	was	used	to	identify	determinants	of	self-	sampling	inten-
tions.	A	purposive	subsample	of	19	women	who	reported	low	self-	sampling	intentions	
were	interviewed.	Interviews	were	framework-	analysed.
Results: Most	survey	participants	(N=133,	69.3%)	intended	to	HPV	self-	sample.	Lower	
intention	was	associated	with	 lower	self-	efficacy	 (OR=24.96,	P≤.001),	 lower	educa-
tion	(OR=6.06,	P≤.05)	and	lower	perceived	importance	of	HPV	as	a	cause	of	cervical	
cancer	 (OR=2.33,	P≤.05).	 Interviews	 revealed	personal	 and	 system-	related	barriers.	
Personal	barriers	included	a	lack	of	knowledge	about	HPV	self-	sampling,	women’s	low	
confidence	in	their	ability	to	self-	sample	correctly	and	low	confidence	in	the	subse-
quent	results.	System-	related	factors	included	a	lack	of	confidence	in	the	rationale	for	
modifying	 the	 current	 cervical	 screening	 programme,	 and	 concerns	 about	 sample	
	contamination	and	identity	theft.
Conclusions: Insights	gained	from	this	research	can	be	used	to	guide	further	enquiry	
into	the	possibility	of	HPV	self-	sampling	and	to	help	inform	future	policy	and	practice.	
Personal	 and	 system-	related	 barriers	 including	 low	 confidence	 in	 the	 reasons	 for	
changing	current	cervical	screening	provision	need	to	be	addressed,	should	HPV	self-	
sampling	be	incorporated	into	the	cervical	screening	programme.
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1  | INTRODUCTION
Cervical	cancer	is	the	second	most	common	cancer	in	women	world-
wide with 527 000 new cases annually.1	 In	 the	UK,	 cervical	 cancer	
is	 the	 third	 most	 common	 gynaecological	 cancer	 after	 ovarian	 and	
uterine cancers2	and	the	second	most	commonly	diagnosed	cancer	in	
women	aged	under	45	years.3	Cervical	screening	is	routinely	offered	to	
all	eligible	women	in	the	UK	using	cervical	cytology	by	National	Health	
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Service	 (NHS)	 cervical	 screening	 programmes.	 Cervical	 screening	 is	
offered	to	women	between	the	ages	of	25	and	64	years	 in	England,	
Wales,	Northern	Ireland	and	Scotland.	Women	under	50	years	of	age	
are	invited	for	screening	every	3	years,	whilst	women	over	50	years	of	
age	are	invited	for	screening	every	5	years.	Cervical	screening	is	free	
and	offered	by	regional	NHS	cervical	screening	programmes.
Over	 the	 past	 decade,	 cervical	 screening	 coverage	 has	 been	
steadily	declining	 throughout	 the	UK.4,5	Cervical	 screening	uptake	 is	
below	 the	NHS	 cervical	 screening	 target	 of	 80%	 needed	 to	 ensure	
cost-	effectiveness	 and	 to	 significantly	 reduce	 cervical	 cancer	 inci-
dence.6	Non-	attenders	are	at	higher	risk	of	developing	cervical	cancer.7 
Younger	age,8,9	high	deprivation10	and	being	from	an	ethnic	minority	
background11	 have	 been	 associated	 with	 poor	 uptake	 of	 cervical	
screening.	 Inconvenient	 appointment	times,12	 gender	of	 the	medical	
practitioner,13	embarrassment,14	lack	of	trust	in	health	professionals,15 
concerns	about	discomfort16	and	the	inconvenience	of	having	to	make	
appointments9,17	have	been	identified	as	barriers	to	cervical	screening.
The	main	aetiological	agent	in	the	development	of	cervical	cancer	is	
a	sexually	transmitted	infection	of	a	viral	nature	called	human	papillo-
mavirus	(HPV).18	HPV	infections	are	common,	and	most	sexually	active	
men	and	women	will	become	infected	with	HPV	at	some	point	in	their	
lives.19	Although	in	most	cases,	the	infection	will	clear	on	its	own,20 per-
sistent	high-	risk	types	of	HPV	(oncogenic)	are	associated	with	cancers	
of	the	cervix,	vulva,	vagina,	penis,	anus	and	rectum.	The	high-	risk	types	
of	HPV	16	and	18	are	known	to	account	for	70%	of	all	cervical	cancer	
cases.	 The	 identification	 of	 high-	risk	 types	 of	 human	 papillomavirus	
(HPV)	as	a	 cause	of	 cervical	 cancer	has	 facilitated	cervical	 screening	
using	HPV	DNA	assays.21	HPV	testing	has	a	higher	sensitivity	for	high-	
grade	precancerous	disease	than	cytology	and	may	extend	screening	
intervals	and	reduce	the	number	of	colposcopy	examinations	in	women	
with	borderline	or	 low-	grade	dyskaryosis	on	cervical	 cytology.22 The 
evaluation	of	how	to	incorporate	HPV	testing	into	the	cervical	screen-
ing	programme	began	in	2008	in	England	with	the	Sentinel	Sites	proj-
ect.	The	 use	 of	HPV	 testing	 in	 cervical	 cancer	 screening	 has	 gained	
momentum	in	the	UK,	most	recently	with	the	approval	of	primary	HPV	
screening23	and	the	UK	National	Screening	Committee	recommenda-
tion	that	HPV	testing	is	incorporated	as	a	primary	screening	tool.24
Consequently,	 cervical	 screening	 programmes	 in	 the	 UK	 are	
changing	to	facilitate	a	new	era	of	cervical	screening.	HPV	testing	as	
“test	of	cure”	following	treatment	and	to	triage	women	with	borderline	
and	low-	grade	dyskaryosis	for	high-	risk	HPV	is	currently	being	incor-
porated	throughout	the	UK,25	although	it	is	not	yet	used	as	a	primary	
screening	modality.
Due	 to	 growing	 evidence	 of	 superior	 sensitivity	 and	 negative	
predictive	value	compared	 to	 cervical	 cytology26 and recent recom-
mendations,24	it	seems	that	future	cervical	cancer	screening	in	high-	
resource	settings	such	as	the	UK	will	evolve	to	include	primary	HPV	
testing.	In	fact,	Australia	has	recently	announced	that	HPV	testing	will	
replace	cytology	as	the	primary	cervical	screening	modality	from	2017	
following	 extensive	 review	 (“Renewal”).27	 However,	 implementation	
of	primary	HPV	screening	in	the	UK	will	require	consideration	of	ap-
propriate	screening	intervals,	defining	triage	and	management	policies	
for	HPV-	positive	women,	ensuring	quality	and	adherence	to	revised	
policies,	the	new	type	of	HPV	screening	test	to	be	used	and	its	accept-
ability to women.
Self-	sampling	methods	are	increasingly	advocated	in	tests	for	sex-
ually	transmitted	 infections.28	HPV	self-	sampling	allows	a	woman	to	
collect	a	sample	of	her	own	cells	at	home	for	HPV	DNA	testing	and	
could	be	used	as	a	form	of	HPV	testing	in	the	UK	cervical	screening	
programme.	A	randomized	controlled	trial	exploring	HPV	self-	sampling	
as	 an	 alternative	 strategy	 for	 cervical	 screening	 in	 non-	responder	
women	found	99%	of	96	returned	HPV	self-	samples	to	be	adequate	
for	analysis.7	Low	acceptability	and	uptake	are	major	obstacles	to	the	
successful	 implementation	 of	 any	 new	 screening	 programme19 and 
must	 be	 considered	 during	 policy	 recommendations.	 Previous	 re-
search	conducted	 in	the	UK,	the	Netherlands	and	Canada	has	 iden-
tified	benefits	of	HPV	self-	sampling	including	perceived	convenience	
and	 reduced	 discomfort	 and	 embarrassment	 by	 avoiding	 gynaeco-
logical	examinations.28–32	 In	contrast,	beliefs	that	HPV	self-	sampling	
might	cause	trauma,	concerns	about	not	doing	the	test	properly	and	
a	lack	of	trust	in	the	accuracy	of	results	have	been	identified	as	barri-
ers.17,32,33	Most	research	to	date	has	focused	on	the	views	of	women	
who	are	cervical	screening	non-	attenders;	however,	their	views	may	
not	 reflect	 those	of	women	who	 adhere	 to	 current	 cervical	 screen-
ing	guidelines.	Moreover,	cultural	and	health-	care	system	differences	
between	countries	may	influence	screening	attitudes	and	intentions,	
resulting	in	findings	being	less	applicable	to	different	populations.	In	
the	absence	of	current	UK	policy	regarding	primary	HPV	testing	and	
HPV	 self-	sampling,	 it	 is	 also	 important	 to	 understand	 the	 attitudes	
and	likely	behavioural	responses	of	women	who	are	engaged	with	the	
	existing	cervical	screening	programme.
Self-	efficacy—an	 individual’s	 belief	 in	 their	 capability	 to	 exercise	
control	 over	 challenging	 demands—is	 considered	 to	 be	 one	 of	 the	
most	powerful	predictors	of	health	behaviour.34	Self-	efficacy	has	been	
shown	to	predict	uptake	of	cervical	screening35	and	is	highly	relevant	
to	HPV	self-	sampling	because	women	are	expected	to	take	a	sample	
independently.	Self-	efficacy	is	part	of	the	Health	Belief	Model	(HBM),27 
which	has	proven	relevance	to	preventative	health	behaviour,	such	as	
participation	 in	 screening	 and	vaccination	programmes.36	The	HBM	
proposes	 that	 intentions	 are	 determined	 by	 beliefs	 relating	 to	 sus-
ceptibility	to	and	severity	of	HPV	infection,	perceived	self-	efficacy	in	
being	able	to	correctly	carry	out	self-	sampling,	and	the	perceived	bar-
riers	and	benefits	of	self-	sampling	compared	to	cervical	smear	tests.
This	 study	used	mixed	methods	 to	understand	women’s	attitudes	
and	intentions	regarding	HPV	self-	sampling,	and	in	particular	the	influ-
ence	of	self-	efficacy	on	intentions	to	HPV	self-	sample.	The	overarching	
aim	was	to	generate	recommendations	to	inform	future	policy	and	prac-
tice	in	relation	to	the	possible	introduction	of	primary	HPV	self-	sampling.
2  | METHODS
2.1 | Participants and recruitment
Women	aged	20-	64	years	who	were	resident	in	South	East	Wales	and	
gave	written	informed	consent	were	approached	to	take	part	 in	the	
study	during	2012-	2013.	The	main	recruitment	source	was	Cervical	
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Screening	Wales,	 with	 supplementary	 recruitment	 through	 primary	
care	and	sexual	health	clinics,	 local	community	groups	and	snowball	
sampling.	Supplementary	recruitment	was	needed	to	ensure	that	the	
target	sample	size	was	achieved	and	to	help	increase	sample	hetero-
geneity.	It	was	calculated	that	a	survey	sample	size	of	172	participants	
would	achieve	90%	power	to	detect	an	odds	ratio	of	2	for	the	effect	
of	self-	efficacy	on	intention	to	self-	sample.	Survey	respondents	who	
indicated	willingness	 to	participate	 in	a	 further	 interview	were	pur-
posively	sampled	for	a	lower	intention	to	HPV	self-	sample,	based	on	
their	survey	responses.
2.2 | Ethical approval
The	 study	 received	 approval	 from	 the	 South	 East	 Wales	 Local	
Research	Ethics	Committee	C	(REC:	11/WA/0213)	and	Public	Health	
Wales	Research	and	Development	(REF:	2012PHW0023).
2.3 | Procedure
A	mixed-	methods	design	was	adopted	using	a	cross-	sectional	survey	
and	semi-	structured	interviews,	in	which	HPV	self-	sampling	was	pre-
sented	as	a	hypothetical	cervical	screening	method.	Women	who	were	
recruited	 through	Cervical	Screening	Wales	were	 sent	 an	 invitation	
leaflet	and	 freepost	envelope	with	 their	 standard	cervical	 screening	
invitation	letter	inviting	them	to	express	interest	in	the	study.	Women	
who	were	 interested	 in	 participating	were	 instructed	 to	 fill	 in	 their	
details	on	the	reverse	of	the	recruitment	card	and	to	return	it	using	
the	supplied	prepaid	envelope.	Women	who	returned	the	completed	
recruitment	card	were	then	sent	the	full	participant	pack	and	survey.
For	 the	supplementary	 recruitment,	women	were	approached	to	
participate	 at	 the	 additional	 recruitment	 sites.	 Survey	 respondents	
were	purposively	sampled	for	lower	intention	to	HPV	self-	sample	and	
were	 invited	 to	 take	 part	 in	 a	 semi-	structured	 interview	 conducted	
in	their	homes	or	at	a	suitable	alternative	venue.	All	interviews	were	
audio-	recorded	with	consent,	anonymized	and	transcribed	verbatim.
3  | MATERIALS
3.1 | Survey measures
A	theoretically	based	(HBM)	survey	was	developed	to	measure	wom-
en’s	 attitudes	 and	 intentions	 regarding	 HPV	 self-	sampling,	 in	 order	
to	 examine	 the	 determinants	 of	 anticipated	 uptake.	 Content	 validity	
analysis	with	health	research	experts	facilitated	the	development	of	the	
survey.	The	use	of	patient	and	public	involvement	(PPI)	of	women	eligi-
ble	for	cervical	screening	through	cognitive	interviews	helped	to	ensure	
that	the	format	of	the	survey	was	accessible	and	that	individual	items	
were	 easily	 and	 correctly	 understood.	 Overall,	 the	 survey	 was	 well	
received	by	participants.	Survey	measures	 included	HPV	and	cervical	
cancer	knowledge,	HPV	self-	sampling	intention,	self-	efficacy	in	relation	
to	HPV	self-	sampling,	perceived	susceptibility	to	and	severity	of	HPV	
infection/cervical	cancer,	and	perceived	benefits/barriers	to	HPV	self-	
sampling.	Cervical	 screening	history	and	demographic	variables	were	
also	 included	 (see	Data	 S1	 for	 further	 details).	 All	 HBM	 items	were	
scored	on	5-	point	Likert	response	scales.	Reliable	scales	were	 identi-
fied	through	a	principal	components	analysis	of	items	relating	to	HBM	
a	priori	constructs.	Five	factors	with	eigenvalues	>1.00	were	extracted.	
As	shown	in	Table	1,	factors	were	loaded	in	line	with	theoretical	expec-
tations.	Loading	strength	and	conceptual	issues	were	considered	when	
deciding	which	a	priori	 item	should	be	 retained	on	each	component.	
The	internal	reliability	of	factor-	derived	scales	was	variable.	Intention	to	
HPV	self-	sample	(α=0.93),	self-	efficacy	(α=0.90)	and	benefits	to	cervical	
screening	(α=0.80)	exhibited	high	internal	reliability,	whilst	barriers	to	
HPV	self-	sampling	(α=0.58),	benefits	to	HPV	self-	sampling	(α=0.55)	and	
barriers	to	cervical	screening	(α=0.44)		exhibited	low	internal	reliability.
3.2 | Interviews
Interviews	were	conducted	by	DW	using	a	semi-	structured	interview	
schedule	(Data	S2)	and	focused	on	understanding	participant	percep-
tions	of	primary	HPV	self-	sampling,	if	it	was	incorporated	into	the	cer-
vical	screening	system.	The	interview	schedule	was	theory-	based	and	
drew	on	the	extended	Health	Belief	Model	constructs	and	concepts	
identified	as	significantly	associated	with	intention	to	self-	sample	dur-
ing	survey	analysis.	The	interview	schedule	was	divided	into	two	sec-
tions	which	explored	perceptions	relating	to	(i)	HPV	self-	sampling	and	
HPV	in	general,	and	(ii)	experiences	of	cervical	smear	tests.	Sampling	
continued	until	no	new	significant	or	relevant	themes	of	 interest	to	
the	study	objectives	were	identified.
3.3 | Analysis
Survey	 data	 were	 analysed	 using	 SPSS	 for	 Windows	 version	 20.	
Participants	with	missing	data	were	excluded	from	analyses.	Descriptive	
statistics	were	used	to	characterize	 the	sample,	 followed	by	univari-
ate	analyses	to	examine	preliminary	associations	between	intention	to	
self-	sample,	sociodemographic	and	HBM	factors,	HPV	knowledge	and	
past	cervical	screening	history	(chi-	square	tests	or	independent	t-	tests	
as	appropriate).	Logistic	regression	was	used	to	identify	the	strongest	
predictors	of	intention	to	self-	sample,	with	a	binary	intention	outcome	
measure	 entered	 as	 the	dependent	 variable	 (higher	 intention	 versus	
lower	 intention	to	HPV	self-	sample).	Due	to	non-	normal	distribution	
of	the	intention	measure,	a	binary	intention	measure	was	created	from	
participants’	Likert	scale	responses	(1-	5).	Those	who	were	classified	as	
having	a	higher	intention	to	HPV	self-	sample	scored	4	or	5	on	all	three	
intention	items,	whilst	those	who	scored	3	or	under	on	any	of	the	three	
intention	items	were	classified	as	having	a	lower	intention	to	HPV	self-	
sample	(see	Data	S1	for	details).	Statistically	significant	variables	iden-
tified	during	univariate	analyses	 (P<.05)	were	modelled	to	determine	
their	effects	on	self-	sampling	intention.
Interviews	were	analysed	by	DW	using	a	framework	approach.37 
Following	 familiarization	with	 the	data,	a	 framework	was	developed	
based	on	a	priori	constructs	(as	identified	in	the	survey	and	HBM)	and	
new	themes	relevant	to	the	research	question	emerging	from	the	data	
as	discussed	among	the	research	group.	The	framework	was	expanded	
and	modified	during	the	analysis	and	was	used	to	filter	and	classify	all	
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data.	Twenty-	five	per	cent	of	transcripts	were	double-	coded	by	MD,	
with	inter-	rater	agreement	satisfactory	at	85%	(620	of	826	codes).38 
Discrepancies	in	coding	were	resolved	by	discussion.
4  | RESULTS
Of	 the	11	961	women	who	 received	 a	 recruitment	 leaflet	with	 their	
cervical	screening	invitation/recall	letter	from	Cervical	Screening	Wales,	
840	 returned	an	expression	of	 interest	 in	 the	 study	and	were	 sent	a	
study	recruitment	pack.	One	hundred	and	thirty-	seven	of	840	(16.31%)	
women	who	received	a	recruitment	pack	completed	the	survey.	A	fur-
ther	57	women	were	recruited	through	GP	surgeries,	community	groups	
and	sexual	health	clinics	to	increase	sample	size	and	representation.	The	
final	survey	sample	therefore	consisted	of	a	total	194	participants,	137	
(71%)	of	whom	were	recruited	through	Cervical	Screening	Wales	and	
57	 (29%)	 from	supplementary	 recruitment	 sources.	Nineteen	women	
who	had	consented	to	be	contacted	for	an	interview	and	who	were	clas-
sified	by	the	survey	as	less	likely	to	HPV	self-	sample	were	interviewed.	
Figure	1	demonstrates	the	final	survey	sample.
4.1 | Sample characteristics
Most	survey	participants	were	of	White	ethnicity,	 in	the	31-	to	49-	
year	age	group,	were	highly	educated	and	were	home	owners.	The	
majority	had	attended	a	cervical	screen	within	the	last	4	years.	Nearly	
half	(43.0%)	of	participants	had	received	an	abnormal	smear	test	re-
sult,	and	approximately	a	quarter	(18.2%)	had	received	treatment	for	
cervical	 abnormalities.	A	 small	 proportion	of	women	knew	a	 family	
member/friend	diagnosed	with	cervical	cancer	(13.5%),	and	some	had	
known	someone	who	had	died	of	cervical	cancer	(5.7%).	Table	2	illus-
trates	participant	characteristics.	The	subset	of	interview	participants	
was	aged	between	23	and	63	years.	Most	were	from	a	White	back-
ground	(n=17)	and	educated	to	a	degree	level	(n=10).	Over	half	had	
received	a	previous	abnormal	cervical	smear	test	result	(n=12).
4.2 | Survey results
Overall,	most	women	(N=133,	69%)	reported	high	intention	to	HPV	
self-	sample.	HPV	knowledge	was	low:	31.4%	of	participants	had	not	
F IGURE  1 Participant	recruitment	sites
TABLE  1 Final	rotated	PCA	of	Health	Belief	Model	constructs	relating	to	HPV	self-	sampling.
Item Factor I II III IV V
How certain are you that you would be able to place the 
swab into the tube?
0.890
How certain are you that you would be able to carry out 
the	self-	sampling	procedure	despite	other	
commitments?
0.884
How certain are you that you would be able to carry out 
the	sampling	procedure?
0.877
How	certain	are	you	that	you	would	be	able	to	send	off	
the	completed	test	within	the	time	allowed?
0.836
How certain are you that you would do the test well 
enough?
0.703 −0.378
I	wouldn’t	trust	the	results	of	the	self-	sampling	kit. 0.834
I	would	be	worried	about	the	self-	sampling	kit	getting	
lost	in	the	post	and	not	reaching	the	laboratory.
0.710 0.417
I	am	worried	that	I	would	hurt	myself	using	the	
self-	sample	kit.
−0.376 0.576
Using	a	self-	sampling	kit	would	be	less	embarrassing	
than	having	a	GP	or	nurse	do	a	smear	test.
0.818
Using	a	self-	sampling	kit	would	mean	that	no	one	will	
know	that	I	am	having	cervical	screening.
0.738
Compared	with	most	women	your	age,	how	likely	do	you	
think	it	is	that	you	will	come	into	contact	with	HPV?
0.837
How	serious	an	infection	do	you	think	HPV	is? 0.910
Items	in	bold	were	retained	on	the	factors.
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heard	of	HPV	before	participating	in	the	study,	25%	(N=41)	believed	
that	HPV	could	be	transmitted	by	means	other	than	sexual	contact,	
32.3%	of	women	believed	that	HPV	could	be	treated	with	medicines,	
and	51.6%	believed	that	HPV	could	not	clear	up	on	its	own.
Preliminary	 associations	 between	 independent	 variables	 and	
intention	 (Supplementary	 materials	 3	 and	 4)	 indicated	 that	 lower	
intention	to	self-	sample	was	significantly	associated	with	lower	educa-
tional	attainment	(P<.05),	White	ethnicity	(P<.01),	 lower	self-	efficacy	
(P≤.001),	fewer	perceived	benefits	(P<.002)	and	more	perceived	barri-
ers	(P<.001)	to	HPV	self-	sampling,	fewer	perceived	benefits	of	smear	
tests	 (P<.028),	 low	HPV	knowledge	 (P<.02)	 and	 the	perception	 that	
HPV	is	not	an	 important	cause	of	cervical	cancer	 (M4.14,	S.D.	0.91,	
P<.007).
The	 regression	 model	 was	 significant	 (X2	 [14,	 N=174]=98.120,	
P<.001),	 indicating	 that	 it	was	 able	 to	 distinguish	 between	women	
who	had	a	 lower	or	higher	 intention	to	HPV	self-	sample.	The	model	
correctly	classified	83.3%	of	cases	and	explained	between	43.1%	and	
61.2%	of	variance	in	intention	to	self-	sample.	Self-	efficacy	in	relation	
to	HPV	self-	sampling	had	the	strongest	influence	on	intention	(P<.001,	
OR=24.96,	95%	CI	6.34-	98).	Higher	educational	level	was	also	asso-
ciated	with	 higher	 intention	 to	 self-	sample	 (P=.016,	 OR=6.06,	 95%	
CI	1.40-	26.14).	Women	with	a	lower	intention	perceived	HPV	as	less	
important	in	causing	cervical	cancer	(P=.034,	OR=2.33,	95%	CI	1.07-	
5.07)	and	perceived	more	barriers	(P	<.001,	OR=0.663,	95%	CI	0.53-	
0.82)	and	fewer	benefits	to	self-	sampling	(P=.012,	OR=1.36,	95%	CI	
1.07-	1.74)	and	cervical	smear	tests	(P=.016,	OR=1.43,	95%	CI	1.07-	
1.91)	than	women	with	a	higher	intention	to	self-	sample	(Table	3).
4.3 | Interview results
Qualitative	analysis	revealed	the	following	key	themes	as	influences	
on	women’s	lower	intentions	to	primary	HPV	self-	sample.	A	summary	
of	identified	barriers	to	HPV	self-	sampling	intentions	is	presented	in	
Table 4.
HPV knowledge
Most	women	did	not	know	what	caused	cervical	cancer.	Some	attrib-
uted	cervical	cancer	to	lifestyle	factors,	genetic	factors	or	something	
that just happens.
I think it’s more a genetic thing and passed down 
(P18)
lifestyle and your diet and um stress I guess, all sorts of 
things 
(P17)
Consequently,	 women	 had	 very	 little	 knowledge	 of	 HPV	 and	 re-
ported	embarrassment	about	their	lack	of	knowledge.
I don’t know nothing at all about it 
(P4)
I’m a bit embarrassed that I don’t know more about it 
(P11)
Women	also	discussed	sex	education	and	stated	that	they	had	not	
been	 taught	about	HPV	or	 its	 link	with	cervical	 cancer.	Some	women	
acknowledged	that	they	had	been	regular	cervical	smear	attenders	from	
a	young	age,	but	that	the	role	of	HPV	in	cervical	cancer	was	never	ex-
plained	to	them.	Consequently,	women	felt	that	more	education	about	
cervical	cancer	and	HPV	was	needed.
TABLE  2 Participant	characteristics
Characteristic N (%)
Age
Under	30 59 30.6
31-	49 78 40.4
50+ 56 29.0
Educational	level
GCSE 43 22.8
Further	education 69 36.5
Degree	or	above 77 40.7
Home ownership
Home owner 125 65.4
Not	a	home	owner 66 34.6
Ethnicity
White 169 88.5
Non-	White 22 11.5
Previous	cervical	screening
Yes 185 95.4
No 9 4.6
Time elapsed since last smear test
Within	4	years 169 90.8
Over	4	years 6.5 6.5
Don’t	know 2.7 2.7
History	of	abnormal	smear	test	result
Yes 75 43.0
No 106 57.0
Treatment	for	cervical	abnormalities
Yes 34 18.2
No 151 80.7
Don’t	know 2 1.1
Family/friend	diagnosed	with	cervical	cancer
Yes 26 13.5
No 164 75.1
Don’t	know 22 11.4
Family/friend	bereavement	due	to	cervical	cancer
Yes 11 5.7
No 164 85.0
Don’t	know 18 9.3
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basically my generation was never educated in anything 
like that, you know especially with school with sex educa-
tion … so I think for me I’m a missed generation to under-
stand what it is fully 
(P10)
Understanding HPV self- sampling
Women	 had	 a	 basic	 understanding	 of	 HPV	 self-	sampling,	 which	
was	attributed	 to	 the	description	of	what	HPV	self-	sampling	would	
involve	 which	 was	 included	 in	 their	 participant	 information	 packs.	
However,	women	rationalized	their	understanding	 in	the	context	of	
cervical	smear	tests	and	perceived	similarities.	Most	women	believed	
that	 the	 self-	sampling	 kit	would	 involve	 collection	of	material	 from	
the	cervix	and	some	also	believed	that	a	speculum	might	need	to	be	
used.	Primarily,	women	were	concerned	 that	 this	would	be	difficult	
to	perform.
my only concern would be am I putting it in far enough, 
because obviously when they do a smear test they open 
up your sort of cervix type thing and then they take, it’s in 
quite deep to take the sample and it would be am I insert-
ing it high enough?
(P17)
Barriers to self- sampling
Availability	 of	 a	 cervical	 smear	 was	 an	 important	 influence	 on	 in-
tention	to	self-	sample.	Women	stated	that	their	 intention	would	be	
highly	influenced	by	the	availability	of	an	alternative,	and	often	saw	
TABLE  3 Logistic	regression	predicting	lower/higher	intention	to	self-	sample
B S.E. Wald df P Odds Ratio
95% C.I.
Lower Upper
Educational	level
Up	to/including	GCSEa 6.147 2 .046
Further	education,	no	degree 0.79 0.69 1.328 1 .249 2.21 0.574 8.478
Degree	or	above 1.80 0.75 5.835 2 .016 6.06 1.405 26.144
Ethnicity 1.228 0.789 2.423 1 .120 3.414 0.727 16.028
HPV	knowledge	prior	to	study −0.191 0.583 0.107 1 .743 0.826 0.263 2.591
Perceived	self-	efficacy 
0=lower,	1=higher	self-	efficacy
3.22 0.69 21.198 1 <.001 24.96 6.346 98.201
Perceived	importance	of	HPV	in	
causing	cervical	cancer 
1=not	important,	5=very	important
0.84 0.39 4.502 1 .034 2.32 1.067 5.070
Perceived	benefits	of	HPV	
self-	sampling. 
2=less	benefits,	10=most	benefits
0.31 0.12 6.306 1 .012 1.36 1.070 1.735
Perceived	barriers	to	HPV	self-	
sampling 
3=less	barriers,	15=most	barriers
−0.41 0.11 14.136 1 <.001 0.66 0.535 0.821
Perceived	susceptibility	to	HPV	
infection 
1=less	susceptible,	5=more	
susceptible
0.091 0.318 0.082 1 .774 1.095 0.587 2.044
Perceived	severity	of	HPV	infection 
1=not	severe,	5=very	severe
−0.538 0.323 2.775 1 .96 0.584 0.310 1.100
Perceived	barriers	to	cervical	smear	
tests 
4=less	barriers,	20=most	barriers
0.178 0.096 3.421 1 .64 1.195 0.989 1.444
Perceived	benefits	of	smear	tests 
2=less benefits,10=most benefits
0.36 0.145 5.830 1 .016 1.43 1.070 1.913
Perceived	susceptibility	to	cervical	
cancer 
1=low	susceptibility,	5=high	
susceptibility
−0.528 0.434 1.476 1 .224 0.590 0.252 1.382
Perceived	severity	of	cervical	cancer 
1=not	severe,	2=very	severe
−0.098 0.252 0.151 1 .698 0.907 0.554 1.485
aUsed	as	a	baseline	group	for	regression	analysis,	CI=confidence	interval.	Items	in	bold	are	significant	at	p<.05
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self-	sampling	as	an	inferior	method	of	cervical	screening	compared	to	
cervical	smears.
if it was the only option that I had then I would do it… but 
if I had an option of having a smear test with the nurse, or 
doing it myself then I’d go with the nurse 
(P1)
Women’s	preference	for	cervical	smear	tests	appeared	to	be	linked	
to	their	confidence	in	the	current	form	of	cervical	screening,	and	con-
cerns	about	losing	access	to	professional	expertise.
you know if you were to use, use the self- sampling would 
you still be able to go then to your GP 
(P3)
The	habitual	nature	of	cervical	screening	behaviour	influenced	wom-
en’s	intentions	to	self-	sample,	with	women	who	expressed	a	preference	
for	the	habitual	behaviour	reporting	a	lower	intention.
Women	were	also	worried	about	sample	contamination	due	to	
sampling	 at	 home,	which	 they	 saw	 as	 a	 non-	sterile	 environment.	
Women	 were	 concerned	 that	 they	 might	 not	 be	 able	 to	 carry	
out	 self-	sampling	 properly	 due	 to	 a	 lack	 of	 practice	 and	medical	
expertise.
my concern would be if a medical person had been doing 
this for all this time, would your sample be good enough? 
(P9).
Women	 reported	 a	 lack	 of	 confidence	 in	 self-	sampling	 results	 by	
saying	that	they	might	have	“missed something”	(P2),	and	some	referred	
to	carrying	out	self-	sampling	incorrectly	and	receiving	a	false-	negative	
result	as	entering	into	a	“life and death situation”	(P1).
When	 discussing	 operational	 factors	 associated	 with	 HPV	 self-	
sampling,	 operational	 themes	 emerged	 including	women’s	 concerns	
that	postal	workers	might	be	unwilling	to	handle	kits	and	worry	about	
identity	theft,	because	self-	sampling	kits	would	contain	DNA	and	per-
sonal details.
if I was a post lady I wouldn’t want to handle someone’s 
thing that’s been in places 
(P4)
One	 of	 the	 most	 recurrent	 and	 unprompted	 operational	 barriers	
was	concern	that	the	laboratory	would	not	confirm	receipt	of	the	self-	
sampling	kit,	which	affected	women’s	confidence	in	the	set-	up	of	a	new	
screening	process:
If there’s nothing about acknowledgment of samples…it 
would make me have entirely less confidence in the whole 
process 
(P5).
Finally,	women	 felt	 that	 the	 imperative	 for	 self-	sampling	might	be	
“politically motivated” and “rushed through”	(P5)	to	cut	costs	for	the	NHS.	
Consequently,	concerns	were	raised	about	withdrawal	of	service:	 “Are 
they taking away my rights to have a smear test?”	(P13).	Barriers	identified	
from	 the	 initial	 framework	 included	worry	about	 the	 self-	sampling	kit	
getting	lost	or	contaminated	in	the	post.
Facilitators to self- sampling
Convenience,	speed	and	the	perception	that	self-	sampling	would	be	
less	 embarrassing,	 uncomfortable	 and	 invasive	 than	 cervical	 smear	
testing	were	facilitators	to	self-	sampling.	Women	had	altruistic	beliefs	
and	reported	that	participating	in	self-	sampling	might	release	health	
practitioner	appointments	to	others	whose	needs	were	more	urgent.	
Some	 women	 also	 felt	 that	 self-	sampling	 would	 be	 a	 more	 cost-	
effective	form	of	screening	and	that	saved	funds	could	be	distributed	
elsewhere
they can help someone who needs more crucial help than 
doing a sample 
(P17).
TABLE  4 Summary	of	identified	barriers	to	HPV	self-	sampling	
from	the	qualitative	phase	of	research
Theme Subthemes
Operational	
factors
Sample	being	lost	in	the	post
Distrust	in	postal	workers	willing	to	handle	
samples
Sample	contamination	or	damage	during	transit
Possibility	of	tampering	with	sample
Identify	theft
Preference	for	expert	systems	(hospital	mail	
services)
Confirmation	that	sample	has	reached	
laboratory.
Confidence	in	
new	HPV	
self-	sampling	
programme
Receipt	of	confirmation	from	laboratory	that	
sample	has	arrived	safely
Continuity	(NHS	provision	of	new	screening)
Access	to	expert	support	(during	and	after	HPV	
self-	sampling,	eg	availability	of	helpline)
Lack	of	confidence	in	reasoning	for	new	system:	
cost-	cutting,	cutting	corners,	withdrawal	of	
current	service	(cervical	smears)
Test	efficacy	compared	to	cervical	smear	tests
Potential	for	
contamination	
of	sample
Unclean	environment
Dropping	kit
Lack	of	
knowledge
Lack	of	HPV	knowledge
Lack	of	knowledge	about	HPV	self-	sampling
Low	self-	efficacy Lack	of	professional	practice
Lack	of	professional	expertise
Consequences	of	not	conducting	test	correctly
Lack	of	confidence	in	result
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it’s worthwhile because the funds would then go to… treat-
ing people with cervical cancer and then getting better 
care
(P9).
5  | DISCUSSION
In	the	event	that	HPV	self-	sampling	is	incorporated	into	UK	cervical	
screening	 programmes,	 research	 examining	 barriers	 and	 facilitators	
will	 be	 important	 to	 highlight	 potential	 problems	with	 acceptability	
and	uptake	and	to	direct	service	recommendations.	The	present	study	
identified	the	impact	of	personal	and	system-	related	barriers	on	wom-
en’s	attitudes	towards	primary	HPV	self-	sampling,	and	their	intention	
to	HPV	 self-	sample.	 In	 addition	 to	 identifying	 barriers	 and	 benefits	
associated	with	HPV	self-	sampling,	the	study	provided	important	in-
sights	 into	women’s	 perceptions	 regarding	 a	 potential	 change	 from	
a	familiar	and	established	health-	care	system	(cervical	smear	testing)	
to	a	new	and	different	type	of	cervical	screening	system	(HPV	self-	
sampling).	Public	concerns	about	 safety	and	acceptability	 should	be	
addressed	 if	 primary	 HPV	 self-	sampling	 is	 to	 become	 incorporated	
into	the	cervical	screening	programme.
Reflecting	 previous	 research,39,40	 barriers	 to	 self-	sampling	 in-
cluded	 a	 lack	 of	 HPV	 knowledge	 and	 concerns	 about	 conducting	
self-	sampling	 properly.17,32	 Although	 concerns	 about	 performing	
self-	sampling	correctly	have	been	identified	in	previous	studies,	the	
current	survey	was	the	first	to	quantify	the	strength	of	the	relation-
ship	between	self-	efficacy	and	intention	to	self-	sample,	and	to	iden-
tify	 key	variables	 for	 subsequent	 in-	depth	 exploration.	This	 study	
highlighted	the	importance	of	self-	efficacy	in	women’s	intention	to	
HPV	 self-	sample,	 and	 qualitative	 results	 provided	 further	 insight	
into	 how	 low	 self-	efficacy	 affected	 women’s	 intentions.	 Women	
believed	 that	 they	might	 fail	 to	 take	 the	 sample	 from	 the	 area	 at	
most	 risk	within	 their	vagina.	Consequently,	women	were	worried	
that	 this	would	 lead	 to	 an	 incorrect	 negative	 result	 and	 that	 they	
would	 not	 get	 an	 opportunity	 for	 repeat	 screening	 until	 the	 next	
routine	screening	round.	When	explaining	their	 lack	of	confidence	
in	self-	sampling	results,	women	referred	to	a	lack	of	personal	exper-
tise,	lack	of	practice	and	a	lack	of	knowledge.	Consequently,	some	
women	perceived	the	introduction	of	primary	HPV	self-	sampling	as	
service	withdrawal	and	stated	that	replacing	primary	screening	with	
HPV	self-	sampling	would	take	away	their	“right”	to	receive	a	cervical	
smear test.
Operational	and	system-	related	barriers	to	HPV	self-	sampling	in-
cluded	fears	about	sample	contamination,	loss	and	identity	theft,	and	
women	wanted	to	receive	an	acknowledgement	that	their	kit	had	ar-
rived	 at	 the	 laboratory	 safely.	Although	women’s	 preference	 for	 re-
turning	samples	directly	to	health-	care	providers	rather	than	through	
the	post	has	been	 identified	 in	previous	studies,33	 this	was	 the	first	
study	to	highlight	specific	concerns	about	identity	theft	and	perceived	
unwillingness	of	postal	workers	to	handle	samples.	Confidence	in	the	
self-	sampling	programme	was	also	influential	because	women	wanted	
to	understand	the	rationale	for	the	set-	up	of	a	new	cervical	screening	
system	and	expressed	concerns	that	it	might	be	motivated	by	political	
and	financial	reasons.
The	present	study	primarily	investigated	the	attitudes	of	cervical	
screening	attenders,	many	of	whom	had	been	 identified	as	having	a	
cervical	abnormality	previously	and	some	of	whom	had	received	treat-
ment	 for	 cervical	 abnormalities.	 By	 exploring	 the	 views	 of	 women	
who	are	engaged	 in	the	current	screening	programme,	 this	 research	
provided	 insight	 into	the	potential	 impact	of	modifying	primary	cer-
vical	 screening	 on	 subsequent	 attendance.	 Ultimately,	 this	 research	
identified	factors	that	might	lead	women	currently	engaged	in	cervical	
screening	to	drop	out	of	cervical	screening,	should	a	new	method	be	
introduced.
Study	limitations	are	acknowledged.	Individual	survey	items	were	
combined	 to	 form	 scales	based	on	 the	HBM	constructs,	with	 some	
exhibiting	 low	 internal	 reliability	 (Cronbach’s	 alpha).	 This	 may	 have	
been	due	to	the	breadth,	such	as	the	possible	benefits	associated	with	
self-	sampling	or	barriers	associated	with	cervical	screening,	or	the	low	
number	of	items	in	the	scale.41	Consequent	examination	of	mean	inter	
item	correlations	revealed	correlations	within	the	accepted	range	of	
0.2	and	0.4,41	 and	 therefore,	we	decided	 to	combine	 the	 items	 into	
scales.	Non-	response	bias	 is	 an	 issue	 commonly	 identified	 in	 postal	
surveys,42	 and	 women	who	 were	 cervical	 screening	 non-	attenders,	
less	educated	and	from	an	ethnic	minority	background	were	less	likely	
to	participate	in	this	study.	Only	137	participants	completed	a	ques-
tionnaire	out	of	11,	961	who	were	initially	sent	a	recruitment	leaflet.	
The	 low	 participation	 rate	 necessitated	 supplementary	 recruitment	
through	community	groups,	GP	practices	and	sexual	health	clinics	to	
achieve	sample	size	as	well	as	to	increase	heterogeneity	of	the	sample.	
The	 response	 rate	 of	 the	 supplementary	 recruitment	was	 unknown	
because	it	was	not	possible	to	record	the	number	of	individuals	who	
were	approached	to	participate	and	those	who	subsequently	declined.	
However,	although	supplementary	recruitment	helped	achieve	sample	
size	and	 representation	of	women	 from	a	broad	age	 range,	 the	ma-
jority	of	participants	were	White,	highly	educated,	cervical	screening	
responders.	 Furthermore,	many	of	 the	participants	had	experienced	
cervical	abnormalities,	which	might	have	influenced	their	perceptions	
of	the	utility	of	HPV	self-	sampling	compared	to	cervical	smear	testing.	
The	 majority	 of	 women	were	 recruited	 through	 Cervical	 Screening	
Wales	and	might	have	been	more	 likely	 to	take	part	 in	 research	be-
cause	 they	were	 already	 engaged	 in	 the	 cervical	 screening	 process.	
The	health	beliefs	of	women	who	participate	in	research	may	be	dif-
ferent	to	those	of	women	who	do	not	participate,	and	therefore	may	
not	represent	population	views.	Further	study	limitations	included	the	
small	sample	size	and	opportunistic	method	of	recruitment,	which	was	
reflected	 in	 the	wide	 confidence	 interval	 observed	 for	 self-	efficacy,	
and	therefore	limited	generalizability	of	findings.	The	cross-	sectional	
nature	of	the	postal	survey	was	useful	for	identifying	the	prevalence	
of	hypothetical	 intention	to	self-	sample	within	a	given	time;43 how-
ever,	 it	was	unable	 to	address	cause	and	effect44	 and	may	have	 led	
to	the	observation	of	inflated	associations	between	variables	due	to	
measurement	at	one	point	in	time.	In	addition,	hypothetical	intentions	
to	self-	sample	may	not	translate	into	actual	uptake	of	a	screening	pro-
gramme.	However,	the	use	of	mixed	methods	enabled	enrichment	of	
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the	survey	findings	and	the	discovery	of	barriers	not	identified	in	the	
survey.45	 The	 type	 of	 information	 that	 is	 obtained	 from	 qualitative	
studies is rich in detail46	and	therefore	necessitated	a	relatively	small	
sample	size	so	that	the	data	could	be	analysed	in	depth.	Interview	par-
ticipants	were	purposively	 recruited	based	on	 low	 intention	to	HPV	
self-	sample	as	measured	by	the	survey.	Different	themes	might	have	
been	 identified	 if	women	who	 had	 a	 higher	 intention	 to	 HPV	 self-	
sample had been recruited.
The	incorporation	of	HPV	testing	in	the	changing	cervical	screen-
ing	 programme	 within	 the	 UK	 presents	 an	 opportunity	 for	 future	
integration	 of	 primary	HPV	 testing	 and	 the	 possibility	 of	HPV	 self-	
sampling.	Evidence	presented	in	the	current	study	suggests	that	per-
sonal	barriers	such	as	lack	of	knowledge	and	low	self-	efficacy	in	ability	
to	 self-	sample	 correctly,	 as	well	 as	 operational	 and	 system	 barriers	
such	as	concerns	about	reasons	for	establishing	a	new	method	for	cer-
vical	 screening,	are	 influential	 in	determining	 intention	 to	engage	 in	
HPV	self-	sampling.	The	insights	gained	can	be	used	to	guide	further	
enquiry	 into	 the	 possibility	 of	HPV	 self-	sampling	 and	 inform	 future	
policy	 and	 practice.	 Should	HPV	 self-	sampling	 be	 incorporated	 into	
the	cervical	 screening	programme,	psycho-	educational	 interventions	
that	 increase	 HPV-	related	 knowledge,	 perceived	 capability	 to	 HPV	
self-	sample	and	confidence	 in	the	reasons	for	setting	up	a	new	pro-
gramme	will	be	needed.
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